Recent quotes:

Hello, neffy: FDA approves first nasal spray for severe allergic reactions – Endpoints News

The FDA ap­proved the nasal spray, to be known as neffy, on Fri­day to treat ana­phy­lax­is in adults and chil­dren who are at least 66 pounds. It’s the first time ever that the FDA has ap­proved a non-in­jectable ep­i­neph­rine prod­uct, the agency said. The ap­proval was based on da­ta from four stud­ies in healthy adults show­ing that neffy pro­duced sim­i­lar lev­els of ep­i­neph­rine in the blood as in­jectable coun­ter­parts.